Overview
Lung cancer is one of the leading causes of cancer-related mortality worldwide. Screening for lung cancer can reduce the risk of death from the disease by up to 20%. It involves the use of low-dose computed tomography (CT) scans to detect early signs of the disease, such as small tumors, nodules, and other lesions. Lung cancer screening is typically recommended for people at high risk, such as those with a history of smoking and other factors. Early detection and treatment can significantly improve the chances of curing the disease, and reduce the risk of death.
Research published in this journal
4 peer-reviewed articles, ranked by relevance. Each links to its DOI.
How this research is being cited
The 4 articles above have been cited 9 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
Jaekwon Seok et al. · 2023 · Journal of Translational Medicine
-
Iman Ehsan et al. · 2022 · Journal of Drug Delivery Science and Technology
-
J. H. Maués et al. · 2020 · Biomolecules
-
2020 · Biomolecules
-
2020 · Bioscience Reports
-
2019 · Journal of Experimental and Clinical Toxicology
-
M. Glade et al. · 2015 · Nutrition (Burbank, Los Angeles County, Calif.)
-
2015 · Nutrition
A sample of recent works citing this journal's research on Lung Cancer Screening, linking to each citing work.